Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. 1999

T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
Department of Molecular and Cell Biology, University of California, Berkeley 94720, USA.

Mouse NK cells express at least seven inhibitory Ly49 receptors. Here we employ a semiquantitative cell-cell adhesion assay as well as class I/peptide tetramers to provide a comprehensive analysis of specificities of Ly49 receptors for class I MHC molecules in eight MHC haplotypes. Different Ly49 receptors exhibited diverse binding properties. The degree of class I binding was related to the extent of functional inhibition. The tetramer studies demonstrated that neither glycosylation nor coreceptors were necessary for class I binding to Ly49 receptors and uncovered peptide-specific recognition by a Ly49 receptor. The results provide a foundation for interpreting and integrating many existing functional studies as well as for designing tests of NK cell development and self-tolerance.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides

Related Publications

T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
July 2000, Journal of immunology (Baltimore, Md. : 1950),
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
August 2006, Immunity,
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
May 2002, Molecular immunology,
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
July 2000, Immunity,
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
June 2001, Journal of immunology (Baltimore, Md. : 1950),
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
July 1995, Nature,
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
January 2002, Journal of immunology (Baltimore, Md. : 1950),
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
February 1996, Immunology today,
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
January 2004, Immunologic research,
T Hanke, and H Takizawa, and C W McMahon, and D H Busch, and E G Pamer, and J D Miller, and J D Altman, and Y Liu, and D Cado, and F A Lemonnier, and P J Bjorkman, and D H Raulet
October 2002, Blood,
Copied contents to your clipboard!